TNF and sarcoma: However, pretreatment of these cell lines with a range of TNF concentrations did not improve the anti-tumor activity of HLA-mismatched PBMCs against these pediatric sarcoma cell lines (Figure 5), indicating that the upregulated co-stimulatory molecules by TNF do not promote the anti-tumor activity of unspecific PBMCs.